2213-0489

Leukemia Research Reports

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 581 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact581 DOIs
2

Attach ORCID iDs across 354 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact354 DOIs
3

Deposit reference lists for 52 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact52 DOIs

DOIs for this ISSN

Showing the top 5 of 581 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Acute myeloid leukemia in the older adults (10.1016/j.lrr.2016.06.001)
Abstract ORCID
87.41 55
2 Mcl-1 as a therapeutic target in acute myelogenous leukemia… (10.1016/j.lrr.2012.11.006)
Abstract ORCID
70.75 25
3 Significant clinical response to JAK1/2 inhibition in a pati… (10.1016/j.lrr.2014.07.002)
Abstract ORCID
70.75 25
4 An exploratory phase 2 study of investigational Aurora A kin… (10.1016/j.lrr.2014.06.003)
Abstract ORCID
69.90 24
5 Human endogenous retrovirus np9 gene is over expressed in ch… (10.1016/j.lrr.2014.06.005)
Abstract ORCID
61.52 16
6 Novel therapeutic options in Acute Myeloid Leukemia (10.1016/j.lrr.2016.09.001)
Abstract ORCID
61.52 16
7 On arsenic trioxide in the clinical treatment of acute promy… (10.1016/j.lrr.2017.03.001)
Abstract ORCID
60.21 15
8 Extramedullary blast crisis of chronic myelogenous leukemia… (10.1016/j.lrr.2013.07.002)
Abstract ORCID
55.70 12
9 Impact of age and induction therapy on outcome of 180 adult… (10.1016/j.lrr.2020.100206)
Abstract ORCID
55.70 12
10 CD47-targeting antibodies as a novel therapeutic strategy in… (10.1016/j.lrr.2021.100268)
Abstract ORCID
55.70 12
11 Successful pregnancy outcome in paroxysmal nocturnal hemoglo… (10.1016/j.lrr.2015.05.001)
Abstract ORCID
52.07 10
12 Somatic mutations of the CREBBP and EP300 genes affect respo… (10.1016/j.lrr.2012.10.002)
Abstract ORCID
50.00 9
13 Acute myeloid leukemia with hepatic infiltration presenting… (10.1016/j.lrr.2021.100251)
Abstract ORCID
50.00 9
14 Combination therapy with interferon and JAK1-2 inhibitor is… (10.1016/j.lrr.2014.05.003)
Abstract ORCID
47.71 8
15 High pseudotumor cerebri incidence in tretinoin and arsenic… (10.1016/j.lrr.2014.07.001)
Abstract ORCID
47.71 8
16 Clonal evolution of AML on novel FMS-like tyrosine kinase-3… (10.1016/j.lrr.2016.01.002)
Abstract ORCID
47.71 8
17 Enhanced international prognostic index in Japanese patients… (10.1016/j.lrr.2016.06.003)
Abstract ORCID
47.71 8
18 A primary esophageal MALT lymphoma patient with Helicobacter… (10.1016/j.lrr.2016.12.001)
Abstract ORCID
47.71 8
19 Thinking about CNS metastasis in cutaneous lymphoma: Analysi… (10.1016/j.lrr.2017.10.001)
Abstract ORCID
47.71 8
20 The sensitivity of the FLT3-ITD detection method is an impor… (10.1016/j.lrr.2020.100198)
Abstract ORCID
47.71 8
21 Real world experience with ropeginterferon alpha-2b (Besremi… (10.1016/j.lrr.2022.100360)
Abstract ORCID
47.71 8
22 Regression of a case of Multiple Myeloma with antiviral trea… (10.1016/j.lrr.2013.01.002)
Abstract ORCID
45.15 7
23 Intravascular large B cell lymphoma (10.1016/j.lrr.2013.12.002)
Abstract ORCID
45.15 7
24 Low body weight and body mass index may be associated with m… (10.1016/j.lrr.2017.04.002)
Abstract ORCID
45.15 7
25 Successful salvage chemotherapy and allogeneic transplantati… (10.1016/j.lrr.2017.07.001)
Abstract ORCID
45.15 7
26 Rewriting the rules for care of MDS and AML patients in the… (10.1016/j.lrr.2020.100201)
Abstract ORCID
45.15 7
27 Isotretinoin is active in the initial management of acute pr… (10.1016/j.lrr.2020.100220)
Abstract ORCID
45.15 7
28 Vincristine and prednisone regulates cellular and exosomal m… (10.1016/j.lrr.2020.100221)
Abstract ORCID
45.15 7
29 Treatment outcome of doxorubicin versus idarubicin in adult… (10.1016/j.lrr.2021.100272)
Abstract ORCID
45.15 7
30 Hemophagocytic lymphohistiocytosis masquerading as progressi… (10.1016/j.lrr.2012.10.003)
Abstract ORCID
42.25 6
31 A successful renal transplantation for renal failure after d… (10.1016/j.lrr.2013.02.003)
Abstract ORCID
42.25 6
32 Hemophagocytic lymphohistiocytosis secondary to T-cell/histi… (10.1016/j.lrr.2014.05.004)
Abstract ORCID
42.25 6
33 An unexpected and devastating adverse event of dasatinib: Rh… (10.1016/j.lrr.2015.11.001)
Abstract ORCID
42.25 6
34 The role of the Exon 13 G571S JAK2 mutation in myeloprolifer… (10.1016/j.lrr.2016.07.003)
Abstract ORCID
42.25 6
35 “Hemophagocytic Lymphohistiocytosis after EBV reactivation a… (10.1016/j.lrr.2017.01.002)
Abstract ORCID
42.25 6
36 Dexrazoxane for cardioprotection in older adults with acute… (10.1016/j.lrr.2017.04.001)
Abstract ORCID
42.25 6
37 Anti-CD19 chimeric antigen receptor targeting of CD19 + acut… (10.1016/j.lrr.2018.03.002)
Abstract ORCID
42.25 6
38 Secondary pure red cell aplasia in multiple myeloma treated… (10.1016/j.lrr.2018.06.005)
Abstract ORCID
42.25 6
39 Effective maintenance treatment with lenalidomide for a pati… (10.1016/j.lrr.2019.04.001)
Abstract ORCID
42.25 6
40 Rapid progression to AML in a patient with germline GATA2 mu… (10.1016/j.lrr.2019.100176)
Abstract ORCID
42.25 6
41 Spontaneous remission of acute myeloid leukemia with NF1 alt… (10.1016/j.lrr.2020.100204)
Abstract ORCID
42.25 6
42 BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy:… (10.1016/j.lrr.2020.100211)
Abstract ORCID
42.25 6
43 Immune checkpoints bone marrow expression as the predictor o… (10.1016/j.lrr.2020.100215)
Abstract ORCID
42.25 6
44 Circulating miRNAs can serve as potential diagnostic biomark… (10.1016/j.lrr.2021.100257)
Abstract ORCID
42.25 6
45 Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Sy… (10.1016/j.lrr.2021.100286)
Abstract ORCID
42.25 6
46 Chromothripsis in a case of TP53-deficient chronic lymphocyt… (10.1016/j.lrr.2012.09.001)
Abstract ORCID
38.91 5
47 Acute myeloid leukemia arising from a donor derived premalig… (10.1016/j.lrr.2014.04.001)
Abstract ORCID
38.91 5
48 The BH3-mimetic ABT-737 effectively kills acute myeloid leuk… (10.1016/j.lrr.2014.06.001)
Abstract ORCID
38.91 5
49 Patterns of relapse and outcome of elderly multiple myeloma… (10.1016/j.lrr.2015.09.002)
Abstract ORCID
38.91 5
50 Expression of a specific extracellular matrix signature is a… (10.1016/j.lrr.2017.12.001)
Abstract ORCID
38.91 5